"The Cancer Vaccine Revolution: Moderna's mRNA Breakthrough"

"Could cancer be treated with a vaccine?" Texas Oncology is studying an mRNA Moderna treatment for melanoma. Melanoma affects 23 persons per 100,000 in the United States each year, with two deaths. The vaccine harnesses the patient's tumor and immune system to combat skin cancer recurrence, indicating a potential transition in Moderna's mRNA vaccines from COVID-19 to cancer prevention. Texas Oncology at Austin and Dallas is one of 165 sites worldwide testing this vaccine for melanoma, along with similar trials for colon and pancreatic malignancies. The study combines Merck's Keytruda and the Moderna vaccination to provide tailored immunotherapy. Patients undergo surgery and a year of immunotherapy, followed by nine vaccines administered over a four to six-month period. What is the goal? To remain cancer-free. Melanoma, the 'bad guy' among skin malignancies, spreads unpredictably and often. Like and Subscribe for more